Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.

Neurosurgical focus

Volumn 20, Issue 4, 2006, Pages

  Kunwar, Sandeep ^a   Chang, Susan M ^a   Prados, Michael D ^a   Berger, Mitchel S ^a   Sampson, John H ^a   Croteau, David ^a   Sherman, Jeffrey W ^a   Grahn, Amy Y ^a   Shu, Vince S ^a   Dul, Jeanne L ^a   Husain, Syed R ^a   Joshi, Bharat H ^a   Pedain, Christoph ^a   Puri, Raj K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EXOTOXIN; HYBRID PROTEIN; IL13 PE38QQR; IL13-PE38QQR; IMMUNOTOXIN; INTERLEUKIN 13;

ADULT; AGED; ARTICLE; BRAIN; BRAIN TUMOR; CHEMISTRY; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG THERAPY; FEMALE; GENETICS; GLIOMA; HUMAN; IMMUNOLOGY; INDWELLING CATHETER; INFUSION PUMP; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; PSEUDOMONAS AERUGINOSA; STANDARD; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BRAIN; BRAIN NEOPLASMS; CATHETERS, INDWELLING; DRUG DELIVERY SYSTEMS; DRUG THERAPY; EXOTOXINS; FEMALE; GLIOMA; HUMANS; IMMUNOTOXINS; INFUSION PUMPS; INTERLEUKIN-13; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PSEUDOMONAS AERUGINOSA; RECOMBINANT FUSION PROTEINS; TREATMENT OUTCOME;

EID: 33747163632     PISSN: None     EISSN: 10920684     Source Type: Journal    
DOI: None     Document Type: Article

References (0)